Literature DB >> 9845269

Effects of nicotine and mecamylamine on rat dorsal raphe neurons.

S Mihailescu1, M Palomero-Rivero, P Meade-Huerta, A Maza-Flores, R Drucker-Colín.   

Abstract

This study investigates the hypothesis that serotonin mediates certain nicotine effects, such as mood improvement and the suppression of the ponto-geniculo-occipital spikes of rapid eye movement sleep. The influence of nicotine (10-300 microM) on the firing rate of dorsal raphe neurons and on serotonin release was therefore, studied in rat midbrain slices. Nicotine increased the firing rate, 10-90%, in 67.5% recorded neurons and decreased it, 8-100%, in the remaining 32.5%. Serotonin release increased 2-7 times after nicotine administration, regardless of firing frequency, but the absolute value of serotonin release was 3 times higher during the decreases than during the increases in firing rate. Mecamylamine (1-20 microM) transiently stimulated the dorsal raphe neurons and competitively antagonized the nicotine-induced serotonin release. The results support the working hypothesis and additionally show that mecamylamine also stimulates dorsal raphe neurons.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9845269     DOI: 10.1016/s0014-2999(98)00658-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  21 in total

1.  Age-dependent effects of initial exposure to nicotine on serotonin neurons.

Authors:  S J Bang; K G Commons
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

Review 2.  Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature.

Authors:  Noah S Philip; Linda L Carpenter; Audrey R Tyrka; Lawrence H Price
Journal:  Psychopharmacology (Berl)       Date:  2010-07-08       Impact factor: 4.530

3.  Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders.

Authors:  L Eugene Arnold; Michael G Aman; Jill Hollway; Elizabeth Hurt; Bethany Bates; Xiaobai Li; Cristan Farmer; Rene Anand; Susan Thompson; Yaser Ramadan; Craig Williams
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-04-26       Impact factor: 2.576

Review 4.  Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states.

Authors:  Marina R Picciotto; Alan S Lewis; Gerrit I van Schalkwyk; Yann S Mineur
Journal:  Neuropharmacology       Date:  2015-01-09       Impact factor: 5.250

Review 5.  Genetic polymorphism of serotonin transporter 5-HTTLPR: involvement in smoking behaviour.

Authors:  Maria Angelica Ehara Watanabe; Sandra Odebrecht Vargas Nunes; Sandra Odebrechet Vargas Nunes; Marla Karine Amarante; Roberta Losi Guembarovski; Julie Massayo Maeda Oda; Kalil William Alves De Lima; Maria Helena Pelegrinelli Fungaro
Journal:  J Genet       Date:  2011-04       Impact factor: 1.166

6.  Behavioral effects of nicotinic antagonist mecamylamine in a rat model of depression: prefrontal cortex level of BDNF protein and monoaminergic neurotransmitters.

Authors:  Sawsan Aboul-Fotouh
Journal:  Psychopharmacology (Berl)       Date:  2014-10-15       Impact factor: 4.530

7.  Harmane inhibits serotonergic dorsal raphe neurons in the rat.

Authors:  Khalid Touiki; Pascal Rat; Robert Molimard; Abderrahman Chait; Renaud de Beaurepaire
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

8.  The development of nicotinic receptors in the human medulla oblongata: inter-relationship with the serotonergic system.

Authors:  Jhodie R Duncan; David S Paterson; Hannah C Kinney
Journal:  Auton Neurosci       Date:  2008-11-05       Impact factor: 3.145

9.  The cholinergic agonist carbachol increases the frequency of spontaneous GABAergic synaptic currents in dorsal raphe serotonergic neurons in the mouse.

Authors:  C Yang; R E Brown
Journal:  Neuroscience       Date:  2013-11-11       Impact factor: 3.590

10.  Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram.

Authors:  Piotr Popik; Ewa Kozela; Martyna Krawczyk
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.